Case file · CIK 0001103804
Established growth manager for technology and healthcare growth signals.
Q4 2025 · SEC 13F case file
KOL-style case note
Established growth manager for technology and healthcare growth signals. This page turns the latest public filing into a shareable research story: what the entity owns, which theme is driving the portfolio, and where to investigate next.
Established growth manager for technology and healthcare growth signals. It belongs in a smart-money radar because its public 13F shows quarterly capital direction and theme preference.
The latest filing's largest public position is MSFT, around 4.1% of the disclosed 13F portfolio. That is the first place to look for the current thesis.
Mixed is the clearest public theme in the portfolio. The important question is whether that theme repeats across the top positions, not just whether one stock worked.
The latest public portfolio is about $37.7B, with 76 lines and roughly 34.7% in the top 10. Higher concentration means a few decisions can explain more of the proxy return.
This is not a live trading signal. It is a quarterly capital map: start with the ranking, inspect the top holdings, then ask whether the manager has a repeatable framework.
13F filings are delayed and incomplete. They do not show shorts, many derivatives, private positions, cash, or current trade timing. Use this page to generate research questions, not to replace diligence.
Smart Money VelocityVelocity score blends 13F value growth, concentration, theme purity, option exposure, and filing history. It is a prioritization score, not a return.
Score blends filing growth, concentration, theme purity, call exposure, and filing history.
13F value
$37.7BQ4 2025, latest public filingGrowth since first filing
1.40x$26.9B → $37.7BReporting lag13F filings arrive after the quarter ends. The page shows a delayed public snapshot, not live positions.
45dQuarter-end snapshot, not live positionsThis is not actual fund performance. Returns and rankings use public disclosures after they become visible, not private NAV or live trading.
Disclosure workflow
Every number is anchored to a public quarterly filing. The report date is the portfolio snapshot; the filing date is when the market could actually see it.
Public holdings
| Holding | Theme | Type | Value | % |
|---|---|---|---|---|
| MICROSOFT CORPMSFT · 3,217,642 shares | Software | SH | $1.6B | 4.1% |
| PNC FINL SVCS GROUP INCPNC · 7,287,068 shares | Other | SH | $1.5B | 4.0% |
| TAIWAN SEMICONDUCTOR MFG LTDTSM · 4,914,896 shares | Semis | SH | $1.5B | 4.0% |
| VISA INCV · 3,984,205 shares | Other | SH | $1.4B | 3.7% |
| SCHWAB CHARLES CORPSCHW · 13,872,905 shares | Other | SH | $1.4B | 3.7% |
| DISNEY WALT CODIS · 11,193,504 shares | Other | SH | $1.3B | 3.4% |
| AIR PRODS & CHEMS INCAPD · 4,782,534 shares | Other | SH | $1.2B | 3.1% |
| MCDONALDS CORPMCD · 3,619,215 shares | Other | SH | $1.1B | 2.9% |
| BRIDGEBIO PHARMA INCBBIO · 14,393,934 shares | Semis | SH | $1.1B | 2.9% |
| FORTIVE CORPFTV · 19,228,265 shares | Other | SH | $1.1B | 2.8% |
| SHERWIN WILLIAMS COSHW · 3,172,308 shares | Other | SH | $1B | 2.7% |
| BOEING COBA · 3,953,087 shares | Other | SH | $858.3M | 2.3% |
| ALPHABET INCGOOGL · 2,666,272 shares | Consumer | SH | $834.5M | 2.2% |
| ADVANCED MICRO DEVICES INCAMD · 3,742,191 shares | Other | SH | $801.4M | 2.1% |
| INTERCONTINENTAL EXCHANGE INICE · 4,803,197 shares | Other | SH | $777.9M | 2.1% |
| TESLA INCTSLA · 1,699,741 shares | Consumer | SH | $764.4M | 2.0% |
| T-MOBILE US INCTMUS · 3,754,218 shares | Other | SH | $762.3M | 2.0% |
| AMAZON COM INCAMZN · 3,126,816 shares | Consumer | SH | $721.7M | 1.9% |
| CAPITAL ONE FINL CORPCOF · 2,952,317 shares | Other | SH | $715.5M | 1.9% |
| JOHNSON CTLS INTL PLCJCI · 5,918,707 shares | Other | SH | $708.8M | 1.9% |
| DRAFTKINGS INC NEWDKNG · 19,119,912 shares | Other | SH | $658.9M | 1.7% |
| JPMORGAN CHASE & CO.JPM · 1,905,982 shares | Other | SH | $614.1M | 1.6% |
| ROSS STORES INCROST · 3,167,479 shares | Other | SH | $570.6M | 1.5% |
| GENERAL MTRS COGM · 6,806,095 shares | Other | SH | $553.5M | 1.5% |
| MID-AMER APT CMNTYS INC59522J103 · 3,880,048 shares | Other | SH | $539M | 1.4% |
| CAMDEN PPTY TRAMD · 4,764,495 shares | Semis | SH | $524.5M | 1.4% |
| DICKS SPORTING GOODS INCDKS · 2,572,969 shares | Other | SH | $509.4M | 1.4% |
| CELESTICA INCCLS · 1,699,236 shares | Other | SH | $502.3M | 1.3% |
| CSX CORPCSX · 13,817,539 shares | Other | SH | $500.9M | 1.3% |
| ADAPTIVE BIOTECHNOLOGIES CORADPT · 29,993,708 shares | Other | SH | $487.1M | 1.3% |
| SEA LTDSE · 3,671,545 shares | Other | SH | $468.4M | 1.2% |
| HCA HEALTHCARE INCHCA · 999,180 shares | Other | SH | $466.5M | 1.2% |
| THERMO FISHER SCIENTIFIC INCTMO · 793,187 shares | Other | SH | $459.6M | 1.2% |
| REGAL REXNORD CORPORATIONRRX · 3,223,940 shares | Other | SH | $452.4M | 1.2% |
| CARVANA COCVNA · 1,061,533 shares | Consumer | SH | $448M | 1.2% |
| CHEWY INCCHWY · 13,536,645 shares | Other | SH | $447.4M | 1.2% |
| API GROUP CORPAPG · 11,537,518 shares | Other | SH | $441.4M | 1.2% |
| STELLANTIS N.VSTLA · 39,062,551 shares | Other | SH | $434.3M | 1.2% |
| CARNIVAL CORPCCL · 14,061,827 shares | Other | SH | $429.4M | 1.1% |
| UBS GROUP AGUBS · 9,128,817 shares | Other | SH | $426M | 1.1% |
| UNITEDHEALTH GROUP INCUNH · 1,197,273 shares | Other | SH | $395.2M | 1.0% |
| BIOMARIN PHARMACEUTICAL INCBMRN · 6,036,936 shares | Semis | SH | $358.8M | 0.95% |
| SAIA INCSAIA · 1,088,582 shares | Other | SH | $355.4M | 0.94% |
| TIC SOLUTIONS INCTIC · 34,360,000 shares | Other | SH | $347.4M | 0.92% |
| CHUBB LIMITEDCB · 1,013,839 shares | Other | SH | $316.4M | 0.84% |
| PROGRESSIVE CORPPGR · 1,331,538 shares | Other | SH | $303.2M | 0.80% |
| LENNOX INTL INC526107107 · 621,311 shares | Other | SH | $301.7M | 0.80% |
| TRADEWEB MKTS INC892672106 · 2,768,659 shares | Other | SH | $297.7M | 0.79% |
| MEDLINE INCMDLN · 6,959,157 shares | Other | SH | $292.3M | 0.78% |
| AON PLCAON · 783,650 shares | Other | SH | $276.5M | 0.73% |
| GALLAGHER ARTHUR J & COAJG · 1,040,977 shares | Other | SH | $269.4M | 0.71% |
| BANK AMERICA CORPBAC · 4,494,629 shares | Other | SH | $247.2M | 0.66% |
| BOSTON SCIENTIFIC CORPBSX · 2,509,808 shares | Other | SH | $239.3M | 0.64% |
| DIGITAL RLTY TR INC253868103 · 1,507,988 shares | Compute | SH | $233.3M | 0.62% |
| LOWES COS INCLOW · 912,040 shares | Other | SH | $219.9M | 0.58% |
| FIGMA INCFIG · 5,752,388 shares | Other | SH | $215M | 0.57% |
| ITAU UNIBANCO HLDG S AITUB · 28,396,545 shares | Other | SH | $203.3M | 0.54% |
| AMER SPORTS INCAS · 4,814,290 shares | Other | SH | $179.8M | 0.48% |
| RALLIANT CORPRAL · 3,162,630 shares | Other | SH | $161M | 0.43% |
| RIOT PLATFORMS INCRIOT · 12,428,894 shares | DC Bitcoin | SH | $157.5M | 0.42% |
| NEWAMSTERDAM PHARMA COMPANYNAMS · 4,203,567 shares | Semis | SH | $147.5M | 0.39% |
| ROIVANT SCIENCES LTDROIV · 6,443,191 shares | Other | SH | $139.8M | 0.37% |
| IQVIA HLDGS INC46266C105 · 619,236 shares | Other | SH | $139.6M | 0.37% |
| SIONNA THERAPEUTICS INCSION · 3,195,181 shares | Other | SH | $131.4M | 0.35% |
| INHIBRX BIOSCIENCES INCINBX · 1,437,705 shares | Other | SH | $113.6M | 0.30% |
| PHARVARIS N VPHVS · 3,653,310 shares | Other | SH | $101.4M | 0.27% |
| COSTAR GROUP INCCSGP · 1,442,582 shares | Other | SH | $97M | 0.26% |
| WEST PHARMACEUTICAL SVSC INC955306105 · 295,028 shares | Semis | SH | $81.2M | 0.22% |
| ORUKA THERAPEUTICS INCORKA · 2,666,690 shares | Other | SH | $80.8M | 0.21% |
| STANDARD BIOTOOLS INCLAB · 58,651,170 shares | Other | SH | $75.1M | 0.20% |
| MASIMO CORPMASI · 514,340 shares | Other | SH | $66.9M | 0.18% |
| ORIC PHARMACEUTICALS INCORIC · 6,572,691 shares | Semis | SH | $53.8M | 0.14% |
| TREVI THERAPEUTICS INCTRVI · 3,198,644 shares | Other | SH | $40M | 0.11% |
| GINKGO BIOWORKS HOLDINGS INCDNA · 3,577,128 shares | Other | SH | $29.7M | 0.08% |
| PEPGEN INCPEPG · 3,482,434 shares | Other | SH | $22.7M | 0.06% |
| RALLYBIO CORPRLYB · 4,194,777 shares | Other | SH | $2.9M | 0.01% |
Quarter tape
Signal breakdown
13F value is 1.40x the first tracked filing.
Top ten public lines are 34.7% of the latest report.
76 reportable lines in the latest public filing.
8 tracked quarterly 13F reports in the database or seed layer.
Publisher mode
Evidence layer
13F reports disclose long reportable U.S. securities and long put/call options. They do not show cash, private stakes, shorts, written options, or current live holdings.
Theme tags are deterministic product analysis from issuer, CUSIP, option type, and keyword rules. They are not SEC labels.
Vercel Cron calls the EDGAR ingestion endpoint every day and records per-manager ingestion results.
